Combination of alpha-fetoprotein and neutrophil-to-lymphocyte ratio to predict treatment response and survival outcomes of patients with unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors

BACKGROUND: Immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of hepatocellular carcinoma (HCC). However, long-term survival outcomes and treatment response of HCC patients undergoing immunotherapy is unpredictable. The study aimed to evaluate the role of alpha-fetoprotein (AFP)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Hong-Fei, Feng, Jin-Kai, Xiang, Yan-Jun, Wang, Kang, Zhou, Li-Ping, Liu, Zong-Han, Cheng, Yu-Qiang, Shi, Jie, Guo, Wei-Xing, Cheng, Shu-Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268526/
https://www.ncbi.nlm.nih.gov/pubmed/37322411
http://dx.doi.org/10.1186/s12885-023-11003-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10268526/
https://www.ncbi.nlm.nih.gov/pubmed/37322411
http://dx.doi.org/10.1186/s12885-023-11003-0

Ejemplares similares